Very low but stable glomerular filtration rate after living kidney donation: Is the concept of "chronic kidney disease" applicable to kidney donors?

Clinical and Experimental Nephrology

Volumn 14, Issue 4, 2010, Pages 356-362

  Kido, Ryo ^a   Shibagaki, Yugo ^b   Iwadoh, Kazuhiro ^c   Nakajima, Ichiro ^c   Fuchinoue, Shohei ^c   Fujita, Toshiro ^a   Teraoka, Satoshi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Donor; Nephrectomy; Renal function; Renal transplantation

Indexed keywords

ADULT; AGE; ARTICLE; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE;

AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEPHRECTOMY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78649477478     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0279-y     Document Type: Article

References (42)

1. Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: The Declaration of Istanbul. Lancet. 2008;372:5-6.
2. Johnson EM, Remucal MJ, Gillingham KJ, Dahms RA, Najarian JS, Matas AJ. Complications and risks of living donor nephrectomy. Transplantation. 1997;64:1124-8.
3. Siebels M, Theodorakis J, Schmeller N, et al. Risks and complications in 160 living kidney donors who underwent nephroureterectomy. Nephrol Dial Transpl. 2003;18:2648-54.
4. Velosa JA, Offord KP, Schroeder DR. Effect of age, sex, and glomerular filtration rate on renal function outcome of living kidney donors. Transplantation. 1995;60:1618-21.
5. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet. 1992; 340:807-10.
6. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG. Kidney donors live longer. Transplantation. 1997;64:976-8.
7. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med. 2009;360:459-69.
8. Ramcharan T, Matas AJ. Long-term (20-37 years) follow-up of living kidney donors. Am J Transpl. 2002;2:959-64.
9. Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol. 2001;166:2043-7.
10. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transpl. 2007;7:2333-43.
11. Delmonico F. A report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and medical guidelines. Transplantation. 2005;79(6 Suppl):S53-66.
12. Rook M, Honker HS, van Son WJ, Homan van der Heide JJ, Ploeg RJ, Navis GJ. Predictive capacity of pre-donation GFR and renal reserve capacity for donor renal function after living kidney donation. Am J Transpl. 2006;6:1653-9.
13. 2 in former kidney donors. Nephrology (Carlton). 2007;12:6-600.
14. Berg UB. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transpl. 2006;21:2577-82.
15. Kronborg J, Solbu M, Njolstad I, Toft I, Eriksen BO, Jenssen T. Predictors of change in estimated GFR: A population-based 7-year follow-up from the Tromso study. Nephrol Dial Transpl. 2008;23:2818-26.
16. Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res. 2008;31:433-41.
17. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156-63. (Pubitemid 47012510)
18. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
19. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375-82.
20. Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transpl. 2006;21:2133-43.
21. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908-19.
22. Gracida C, Espinoza R, Cedillo U, Cancino J. Kidney transplantation with living donors: Nine years of follow-up of 628 living donors. Transpl Proc. 2003;35:946-7.
23. Fehrman-Ekholm I, Duner F, Brink B, Tyden G, Elinder CG. No evidence of accelerated loss of kidney function in living kidney donors: Results from a cross-sectional follow-up. Transplantation. 2001;72:444-9.
24. Garg AX, Muirhead N, Knoll G, et al. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70:1801-10.
25. Imai E. Equation for estimating GFR from creatinine in Japan. Nippon Rinsho. 2008;66:1725-9.
26. Wan RK, Spalding E, Winch D, Brown K, Geddes CC. Reduced kidney function in living kidney donors. Kidney Int. 2007;71:1077. (author reply).
27. Bertolatus JA, Goddard L. Evaluation of renal function in potential living kidney donors. Transplantation. 2001;71:256-60.
28. Issa N, Meyer KH, Arrigain S, et al. Evaluation of creatininebased estimates of glomerular filtration rate in a large cohort of living kidney donors. Transplantation. 2008;86:223-30.
29. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266.
30. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow- up study. Kidney Int. 2007;71:159-66.
31. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278-85.
32. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155-61.
33. Halbesma N, Kuiken DS, Brantsma AH, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17:2582-90.
34. Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis. 2004;44:806-14.
35. Poggio ED, Rule AD. A critical evaluation of chronic kidney disease-should isolated reduced estimated glomerular filtration rate be considered a 'disease'? Nephrol Dial Transpl. 2009;24:698-700.
36. Barri Y, Parker T 3rd, Kaplan B, Glassock R. Primum non Nocere: Is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transpl. 2009;9:657-60.
37. Garg AX, Prasad GV, Thiessen-Philbrook HR, et al. Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada. Transplantation. 2008;86:399-406.
38. Kido R, Shibagaki Y, Iwadoh K, et al. How do living kidney donors develop end-stage renal disease? Am J Transpl. 2009;9:2514-9.
39. Ommen ES, Winston JA, Murphy B. Medical risks in living kidney donors: Absence of proof is not proof of absence. Clin J Am Soc Nephrol. 2006;1:885-95.
40. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med. 2006;145:185-96.
41. McClellan W, Warnock DG, McClure L, et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol. 2006;17:1710-5. (Pubitemid 43794674)
42. Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005;68:914-24.